Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Trial symbols : NIPNF save search
Transgene, NEC, and BostonGene Expand Collaboration for Phase I/II Clinical Trial of Neoantigen Cancer Vaccine TG4050
Published: 2024-03-05 (Crawled : 07:00) - globenewswire.com
NIPNF | $68.91 -52.94% 120
|
Technology Services
| Email alert
Add to watchlist
tg4050 vaccine cancer collaboration trial
Global Industrial IoT Market Research Report (2021 to 2026) - by Technology, Industry and Region
Published: 2021-11-16 (Crawled : 13:00) - prnewswire.com
ABLZF | News | $48.065 -32.74% 4.7K
|
Producer Manufacturing
|
| O: -2.07%
H: 0.77%
C: 0.77%
ROK | $269.96 -1.29% 0.0% 1.2M
|
Producer Manufacturing
|
| O: 0.18%
H: 2.4%
C: 1.55%
IBM | News | $181.58 0.06% -0.32% 3M
|
Technology Services
|
| O: -0.65%
H: 0.82%
C: -0.39%
HON | News M | $194.27 1.67% 1.64% 3.6M
|
Producer Manufacturing
|
| O: 0.0%
H: 0.3%
C: -0.56%
GE | News | $148.06 -3.19% 0.0% 9.5M
|
Electronic Technology
|
| O: -1.86%
H: 0.06%
C: -2.64%
ABB | News | $37.13 -0.03% 6.4M
|
Producer Manufacturing
|
| O: -0.48%
H: 0.96%
C: 0.6%
PTC | News | $176.41 0.4% 0.4% 700K
|
Technology Services
|
| O: -2.17%
H: 0.0%
C: 0.0%
INTC | $34.2 -2.4% -2.46% 58M
|
Electronic Technology
|
| O: -0.16%
H: 0.0%
C: 0.0%
CSCO | $48.33 0.46% 0.46% 20M
|
Technology Services
|
| O: 0.38%
H: 0.0%
C: 0.0%
ANSS | News | $322.22 -0.7% -0.71% 420K
|
Technology Services
|
| O: 0.52%
H: 0.0%
C: 0.0%
technology research iot trial
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.